BioPreIOA: Identification of New Predictive Osseointegration Bio-Markers of the Prosthetic Implant in Patients With OsteoArthritis
Study Details
Study Description
Brief Summary
The study involves the isolation and cellular, molecular and proteomic characterization of synoviocytes, osteoblasts and chondrocytes from tissue samples obtained from patients undergoing surgery of endo or arthroplasty for osteoarthritis (Experimental Group) or interventions for other causes such as for example periarticular fracture requiring the implantation of a prosthesis (Control Group)
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Detailed Description
The study involves the isolation and cellular, molecular and proteomic characterization of synoviocytes, osteoblasts and chondrocytes from tissue samples obtained from patients undergoing surgery of endo or arthroplasty for osteoarthritis (Experimental Group) or interventions for other causes such as for example periarticular fracture requiring the implantation of a prosthesis (Control Group) Deeper analysis of micro Ribo Nucleic Acid (RNA) and Non Coding RNA expressed by the synoviocytes, osteoblasts and chondrocytes will be performed in order to understand their possible involvement in pathways of osteogenic differentiation, through suitable experimental in vitro models of co-cultures. In particular, investigators will focus on the cross-talk between synoviocytes and osteoblasts, cell populations involved in the post-surgical articular microenvironment and on which the osteointegration process of the joint prosthesis depends.
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Osteoarthritis Surgery for implantation of a prosthesis in case of Osteoarthritis |
Procedure: Surgery for implantation of a prosthesis
Analysis of micro Ribo Nucleic Acid (RNA) expressed by the synoviocytes, osteoblasts and chondrocytes
Other Names:
|
| Non Osteoarthritis Surgery for implantation of a prosthesis fon non Osteoarthritis cases |
Procedure: Surgery for implantation of a prosthesis
Analysis of micro Ribo Nucleic Acid (RNA) expressed by the synoviocytes, osteoblasts and chondrocytes
Other Names:
|
Outcome Measures
Primary Outcome Measures
- miRNAs and LncRNA [at the time of surgery (Day0)]
expression of miRNAs and LncRNA, from synoviocytes, osteoblasts and chondrocytes detected at the time of surgery
Secondary Outcome Measures
- Biomarkers useful for predicting the efficiency of osseointegration of the implant [at the time of surgery (Day0)]
the mRNAs and the identified proteins will be analyzed through the use of specific software, such as TargetScanPrediction.
- Validation of data obtained on miRNAs and lncRNAs [at the time of surgery (Day0)]
Through in vitro co-culture systems, investigators will evaluate the role of previously identified miRNAs and lncRNAs in cross-talk between osteoblasts and synoviocytes isolated from patients with osteoarthritis.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Male and Female patients > 40 years old hospitalized for surgery of endo- or arthroplasty for Osteoarthritis or for surgery for joint traumatic diseases (eg femoral neck fractures) requiring the implantation of a prosthesis
-
Interval of at least three months from any previous infiltrative treatment of any kind;
-
Patients able to provide written informed consent to the study.
Exclusion Criteria:
-
Severe cognitive defects or psychiatric disorders;
-
Tumor pathologies or concurrent antineoplastic therapies;
-
Autoimmune diseases (rheumatoid arthritis);
-
Surgery that involves the joint
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | IRCCS Istituto Ortopedico Rizzoli | Bologna | BO | Italy | 40136 |
Sponsors and Collaborators
- Istituto Ortopedico Rizzoli
Investigators
- Study Chair: Gianluca Giavaresi, MD, Isituto Ortopedico Rizzoli
Study Documents (Full-Text)
More Information
Publications
- Costa V, Raimondi L, Conigliaro A, Salamanna F, Carina V, De Luca A, Bellavia D, Alessandro R, Fini M, Giavaresi G. Hypoxia-inducible factor 1Α may regulate the commitment of mesenchymal stromal cells toward angio-osteogenesis by mirna-675-5P. Cytotherapy. 2017 Dec;19(12):1412-1425. doi: 10.1016/j.jcyt.2017.09.007. Epub 2017 Oct 27.
- Marijnissen AC, Lafeber FP. Re: E. B. Hunziker. Articular cartilage repair: basic science and clinical progress. A review of the current status and prospects. Osteoarthritis and Cartilage 2002; 10:432-63. Osteoarthritis Cartilage. 2003 Apr;11(4):300-1; author reply 302-4.
- Pelletier JP, Martel-Pelletier J, Abramson SB. Osteoarthritis, an inflammatory disease: potential implication for the selection of new therapeutic targets. Arthritis Rheum. 2001 Jun;44(6):1237-47. Review.
- Zhang M, Lygrisse K, Wang J. Role of MicroRNA in Osteoarthritis. J Arthritis. 2017 Apr;6(2). pii: 239. doi: 10.4172/2167-7921.1000239. Epub 2017 Apr 28.
- BioPreIOA